SaktiChakrabartiMD

PubMed

• Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
  Henry Stitzel, Victoria Wu, Kavin Sugumar, David Bajor, Sakti Chakrabarti, Madison Conces, Lauren Henke, Melissa Lumish, Amit Mahipal, Amr Mohamed, Jordan M Winter, Je...> ;Annals of Surgical Oncology. 2024 Mar 19
• Providing context for the HIPECT4 results.
  Charles, R., Hoehn, R., Ammori, J., Rothermel, L., Winter, J., Chakrabarti, S.> ;Cancer. 2024 Jan 17
• Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy.
  de Ortiz de Choudens, S., Visotcky, A., Banerjee, A., Aldakkak, M., Tsai, S., Evans, D., Christians, K., Clarke, C., George, B., Shreenivas, A., Kamgar, M., Chakrabart...> ;Cancer Medicine. 2023 Dec 22
• Surgical Resection Alone is Associated With Higher Long-Term Survival Than Multiagent Chemotherapy Alone for Patients With Localized Biliary Tract Cancers.
  Elshami, M., Selfridge, J., Ammori, J., Hardacre, J., Bajor, D., Mohamed, A., Chakrabarti, S., Mahipal, A., Winter, J., Ocuin, L.> ;The Journal of Surgical Research. 2024 Mar 1
• FOxTROT Study Results: Some Burning Questions Need Answers.
  Sakti Chakrabarti, Amit Mahipal> ;Journal of Clinical Oncology. 2023 Oct 20
• Differences in the surgical management of early-stage hepatocellular carcinoma at minority versus non-minority-serving hospitals.
  Mohamedraed Elshami, Lauryn Bailey, Richard S Hoehn, John B Ammori, Jeffrey M Hardacre, J Eva Selfridge, David Bajor, Amr Mohamed, Sakti Chakrabarti, Amit Mahipal, Jor...> ;Surgery. 2023 Nov 1
• 1 citations
  Outcome of Patients With Early-Stage Mismatch Repair Deficient Colorectal Cancer Receiving Neoadjuvant Immunotherapy: A Systematic Review.
  Sakti Chakrabarti, Udhayvir Singh Grewal, Kruti Bhagirath Vora, Aparna Raj Parikh, Diana Almader-Douglas, Amit Mahipal, Mohamad Bassam B Sonbol> ;JCO Precision Oncology. 2023 Aug 1
• 1 citations
  Efficacy of Immune Checkpoint Inhibition and Cytotoxic Chemotherapy in Mismatch Repair-Deficient and Microsatellite Instability-High Pancreatic Cancer: Mayo Clinic Exp...
  Tucker Coston, Aakash Desai, Hani Babiker, Mohamad Bassam Sonbol, Sakti Chakrabarti, Amit Mahipal, Robert McWilliams, Wen Wee Ma, Tanios S Bekaii-Saab, John Stauffer, ...> ;JCO Precision Oncology. 2023 Aug 1
• 2 citations
  Impact of perioperative chemotherapy on survival in patients with cholangiocarcinoma undergoing curative resection.
  Hind Hassan, Sakti Chakrabarti, Tyler Zemla, Jun Yin, Vanessa Wookey, Kritika Prasai, Amro Abdellatief, Renuka Katta, Nguyen Tran, Zhaohui Jin, Sean Cleary, Lewis Robe...> ;European Journal of Surgical Oncology. 2023 Nov 1
• Disparities in guideline-compliant care for patients with pancreatic ductal adenocarcinoma at minority-versus non-minority-serving hospitals.
  Mohamedraed Elshami, Richard S Hoehn, John B Ammori, Jeffrey M Hardacre, Jennifer E Selfridge, David Bajor, Amr Mohamed, Sakti Chakrabarti, Amit Mahipal, Jordan M Wint...> ;HPB. 2023 Dec 1
• 2 citations
  Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness.
  Julia C F Quintanilha, Michael H Storandt, Ryon P Graf, Gerald Li, Rachel Keller, Douglas I Lin, Jeffrey S Ross, Richard S P Huang, Alexa B Schrock, Geoffrey R Oxnard,...> ;JCO Precision Oncology. 2023 Jul 1
• Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
  Sri Harsha Tella, Nathan Foster, Shi Qian, Tran Nguyen, Mitesh J Borad, Robert R McWilliams, Steven R Alberts, Wen Wee Ma, Sakti Chakrabarti, Briant Fruth, Jaclynn Wes...> ;The Oncologist. 2023 Oct 3
• 2 citations
  Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemothera...
  Anusha Chidharla, Eliot Rapoport, Samragnyi Madala, Brenda Linares, Weijing Sun, Sakti Chakrabarti, Anup Kasi, Kriti Agarwal> ;International Journal of Molecular Sciences. 2023 Jun 16
• 1 citations
  The predictive impact of dual somatostatin receptor/fluorodeoxyglucose (FDG) positron emission tomography (PET) in metastatic gastroenteropancreatic neuroendocrine tum...
  Amr Mohamed, Sylvia L Asa, Zhenghong Lee, Sree H Tirumani, Qiubai Li, Norbert Avril, David Bajor, Amit Mahipal, Sakti Chakrabarti, J Eva Selfridge, Arash Kardan> ;Journal of Gastrointestinal Oncology. 2023 Apr 29
• Circulating Tumor DNA-Guided Recurrence Risk Assessment in Esophageal and Gastric Cancer: Assay Holds the Key.
  Sakti Chakrabarti, Amit Mahipal> ;JCO Precision Oncology. 2023 Mar 1
• 3 citations
  A glimpse into the future of esophageal carcinoma in the United States: predicting the future incidence until 2040 based on the current epidemiological data.
  Sri Harsha Tella, Kristin Mara, Sakti Chakrabarti, Zhaohui Jin, Amit Mahipal> ;Journal of Gastrointestinal Oncology. 2023 Feb 28
• 2 citations
  Why the Treatment Sequence Matters: Interplay Between Chemotherapy Cycles Received, Cumulative Dose Intensity, and Survival in Resected Early-stage Pancreas Cancer.
  Victoria S Wu, Mohamedraed Elshami, Henry J Stitzel, Jonathan J Lee, Jonathan J Hue, Ravi K Kyasaram, Jeffrey M Hardacre, John B Ammori, Jordan M Winter, Jennifer Eva ...> ;Annals of Surgery. 2023 Oct 1
• Circulating tumor DNA-guided minimal residual disease assessment in colorectal cancer.
  Sakti Chakrabarti, Amit Mahipal> ;Pharmacogenomics. 2023 Jan 1
• Short term safety of coronavirus disease 2019 vaccines in patients with solid tumors receiving systemic therapy.
  Ronald E Cox, Marie Parish, Carolyn Oxencis, Edward Mckenna, Bicky Thapa, Sakti Chakrabarti> ;World journal of clinical oncology. 2022 Jul 24
• A Carcinoma of Unknown Primary (CUP) Patient Treated Successfully With Immunotherapy Upon Recognition of Deficient Mismatch Repair Signature on Liquid Biopsy: A Case R...
  Ronald E Cox, Sakti Chakrabarti> ;Cureus. 2022 Jul 1
• 8 citations
  Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)-Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC).
  Sakti Chakrabarti, Anup Kumar Kasi, Aparna R Parikh, Amit Mahipal> ;Cancers. 2022 Jun 23
• 1 citations
  Tumor Mutational Burden Is a Potential Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Advanced Biliary Tract Cancer.
  Savannah S Liddell, Sakti Chakrabarti, Grant A Wintheiser, Tyler J Zemla, Qian Shi, Sri Harsha Tella, Zhaohui Jin, Vanessa B Wookey, Hind Hassan, Nguyen H Tran, Mitesh...> ;JCO precision oncology. 2022 Jun 1
• 13 citations
  Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer.
  Sakti Chakrabarti, Leslie Bucheit, Jason Scott Starr, Racquel Innis-Shelton, Ardaman Shergill, Hiba Dada, Regina Resta, Stephanie Wagner, Naomi Fei, Pashtoon Murtaza Kasi> ;Journal for immunotherapy of cancer. 2022 Jun 1
• 4 citations
  BESPOKE IO protocol: a multicentre, prospective observational study evaluating the utility of ctDNA in guiding immunotherapy in patients with advanced solid tumours.
  Pashtoon Murtaza Kasi, Sakti Chakrabarti, Sarah Sawyer, Michael Krainock, Andrew Poklepovic, George Ansstas, Minu Maninder, Meenakshi Malhotra, Joe Ensor, Ling Gao, Ze...> ;BMJ open. 2022 May 30
• 6 citations
  Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities.
  Sakti Chakrabarti, Mandana Kamgar, Amit Mahipal> ;Cancers. 2022 May 24
• Join now to see all

Lectures

• Intratumoral CD3+ and CD8+ T-cell densities in patients with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer (mCRC) receiving programmed death-1 (PD-... 
  2019 ASCO Annual Meeting - 6/1/2019